INTRODUCTION
============

In eukaryotes, three nuclear RNA polymerases (Pol) are responsible for the transcription of the genome. Pol I transcribes a single RNA species, the precursor of the large ribosomal RNAs (rRNA) and of the 5.8S rRNA. Pol II transcribes all messenger RNAs and many non-coding RNAs implicated in various processes ranging from splicing, RNAs modification (snoRNAs) or gene regulation (miRNAs). Pol III transcribes the 5S rRNA, the tRNAs and a small number of stable non-coding transcripts ([@gkr737-B1],[@gkr737-B2]). The U6 snRNA (mRNA splicing), RNAse P RNA (tRNA maturation) and 7SL RNA (signal recognition particle) are produced by Pol III in all eukaryotes examined so far, whereas, the RNase MRP RNA (mitochondrial rRNA maturation) is transcribed by Pol II in *Saccharomyces* *cerevisiae* and by Pol III in animals. Other short Pol III products of rather poorly defined functions, such as the vault particle, the Y, 4.5S and BC1 RNAs are largely specific to mammals ([@gkr737-B2]). Finally, the short interspersed repeated elements (SINEs) are retrotransposons originating from class III (i.e. Pol III-transcribed) genes present in hundreds of thousands of copies in mammalian genomes ([@gkr737-B3]). SINEs can be transcribed by the Pol III transcription machinery *in vitro* ([@gkr737-B4]).

The promoters of class III genes are divided into three categories depending on their organization and transcription factor dependence (reviewed in refs 5,6; unless stated otherwise, the nomenclature used for the class III machinery subunits is that of the mammalian transcription system according to ref. 5). Type II promoters of tRNA genes harbor intragenic A and B boxes that are recognized by TFIIIC, a six subunits factor (7 and references therein). Once associated with DNA, TFIIIC positions a second factor, called TFIIIB in yeast or TFIIIB-β in mammals ([@gkr737-B8]), upstream of the transcription start site (TSS). Yeast TFIIIB and mammalian TFIIIB-β consist of the TATA box-binding protein (TBP), BDP1 and BRF1, which are related to TFIIB Pol II general transcription factor. Yeast TFIIIB and mammalian TFIIIB-β recruit Pol III through direct protein--protein interactions ([@gkr737-B9],[@gkr737-B10]). The type I promoter, unique to the 5S rRNA, is located within the transcribed region and requires TFIIIA that acts as an adapter for the binding of TFIIIC. The mammalian U6 promoter, a classical type III promoter, is located upstream of the transcribed region and consists of a proximal sequence element (PSE) recognized by a four-subunit factor variously called the PSE-binding protein (PBP), the PSE transcription factor (PTF), or the snRNA activating protein complex (SNAPc) ([@gkr737-B11; @gkr737-B12; @gkr737-B13]), and a TATA box which is bound by TFIIIB-α, in which the BRF1 subunit of TFIIIB-β is replaced by BRF2 ([@gkr737-B8],[@gkr737-B14],[@gkr737-B15]).

Since Pol III transcribes several rRNAs and the tRNAs, it plays a central role in determining the translational capacity of the cell ([@gkr737-B16]). The regulation of Pol III transcription plays a critical role in cell proliferation and cancer ([@gkr737-B17]). Indeed, artificially increasing tRNA and 5S rRNA transcription causes increased cell proliferation and oncogenic transformation ([@gkr737-B18]).

We discovered that TFIIS, a Pol II transcription elongation ([@gkr737-B19]) and initiation factor in *S. cerevisiae* ([@gkr737-B20],[@gkr737-B21]), also functions as a Pol III general transcription factor ([@gkr737-B22]). Indeed, TFIIS binding could be detected on all class III genes and mutations that affected specifically Pol II or Pol III transcription were identified. Biochemical study of TFIIS role in Pol III transcription in yeast indicated that it stimulates faithful transcription initiation *in vitro*. In mouse, three isoforms of TFIIS, encoded by TCEA1, −2 and −3 exist ([@gkr737-B23; @gkr737-B24; @gkr737-B25]). TCEA1 is expressed ubiquitously, contrary to TCEA2 and −3, which are expressed in spermatocytes or in the liver and kidney, respectively. Whether or not they are implicated in Pol III transcription is presently not known.

RNAs synthesized by Pol III often originate from repeated genes, be it the repeated 5S gene or multiple copies of some tRNA genes, raising the question whether all copies of a gene are transcribed at a given time. In addition, class III transcripts are difficult to predict bioinformatically. The nature of the class III transcriptome was first investigated in the yeast *S. cerevisiae* by analyzing the genome-wide distribution of the Pol III transcription machinery ([@gkr737-B26; @gkr737-B27; @gkr737-B28]). The Pol III transcription machinery was associated with nearly all tRNA genes irrespective of their genomic localization, suggesting that they are transcribed. Only one new class III transcript, snR52 snoRNA, was identified ([@gkr737-B26; @gkr737-B27; @gkr737-B28]). The ChIP-Seq method was very recently applied to the analysis of the Pol III transcription machinery in various human cell lines allowing a complete description of the class III transcriptome ([@gkr737-B29; @gkr737-B30; @gkr737-B31; @gkr737-B32; @gkr737-B33]). Unlike the situation in *S. cerevisiae* where all tRNA genes are transcribed, only a subset of the tRNA genes is bound by the Pol III machinery in human. The identity of the bound tRNA genes varied from one cell type to another. In addition, these studies allowed the identification of a few dozen new loci bound by Pol III.

In *S. cerevisiae*, TFIIIC was present, independently of Pol III, on a small number of genomic locations, called *ETC* loci for extra TFIIIC ([@gkr737-B26]). These *ETC* loci are conserved among yeast species suggesting that they might have a functional role in chromatin organization. Repressing artificially the expression of histones *in vivo* leads to decreased nucleosome abundance. In such a situation, the expression of the *ETC* loci is induced ([@gkr737-B34]). In *Schizosaccharomyces pombe*, the presence of TFIIIC independently of Pol III and TFIIIB marks several boundaries between euchromatin and heterochromatin domains ([@gkr737-B35]). In *S. pombe*, TFIIIC plays an active role in delimiting the boundaries since *cis*-acting mutations that abolish its binding lead to the spreading of heterochromatic marks in regions that are usually euchromatic and as a consequence, lead to transcriptional silencing. Interestingly, a large number of ETCs was also found in human cell lines (1865 in K562 cells and 307 in HeLa cells; ([@gkr737-B30],[@gkr737-B31]). Moreover, the ETCs that were highly enriched for TFIIIC were also often associated with CCCTC-binding factor (CTCF) ([@gkr737-B31]), a protein implicated in insulation and chromosome looping and conformation ([@gkr737-B36]), suggesting a role for TFIIIC in defining repressive domains in human.

In this study, we investigated the distribution of Pol III, BRF1, BRF2, TFIIIC and one of the TFIIS homologs, TCEA1, on the genome of mouse embryonic stem (ES) cells using a highly specific ChIP-seq method that entailed tagged ES cell lines. Our work provided a detailed analysis of the active class III genes in mouse ES cells and led to the discovery of new genes transcribed by this enzyme. We found that only a few hundreds SINEs are transcribed by Pol III. Interestingly, the presence of TCEA1 was detected on the majority of the active class III genes suggesting that it acts as a Pol III transcription factor in mammals. We also took advantage of the genome-wide analysis of TCEA1 to show that it is present at similar levels on paused Pol II peaks of active and inactive genes suggesting that it is not TFIIS recruitment that triggers the passage of Pol II into elongation.

MATERIALS AND METHODS
=====================

Construction of the mouse ES cell lines
---------------------------------------

We used the recombineering technology ([@gkr737-B37]) to generate the targeting vectors that introduce the triple affinity tag in the subunits of Pol III, TFIIIB-α or -β, TFIIIC and TFIIS. The 46C ES cell line ([@gkr737-B38]) was transfected by electroporation with each targeting vector. Cells were plated in D15 medium as described ([@gkr737-B39]) and selected with G418. Individual ES cell colonies were collected 7 days after electroporation, amplified and genotyped by Southern blotting, in order to identify the clones that underwent a homologous recombination event. In these clones, a sequence encoding a 6 Histidine-Flag-HA tag, followed by a neomycin resistance marker flanked by loxP sites, was inserted just after the last codon of the gene encoding the protein to be tagged. For TCEA1, the tag was inserted just after the start codon. The sequence of the insertion cassette is given in the [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1). The integration of the cassette at the right loci was verified by Southern blotting using three or four different restriction enzymes and DNA-polymerase chain reaction (PCR). Transient transfection with a Cre recombinase expression vector was used to remove the selection cassette. The karyotypes of all cell lines were verified. The genes that were modified in the cell lines encoded RPC1 (MGI:2681836), RPC4 (MGI:1914315), BRF1 (MGI:1919558), BRF2 (MGI:1913903), TFIIIC220 (MGI:107887), TFIIIC110 (MGI:1919002), TFIIIC90 (MGI:2138937) and TCEA1 (MGI:1196624), respectively. The expression of the tagged versions of the proteins was verified by western blotting using HA7 anti-HA antibodies (Sigma; [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)).

ES cell lines culture
---------------------

ES cells were cultured on embryonic fibroblast feeder cells blocked with mitomycin C in D15 medium \[Dulbecco\'s Modified Eagle\'s Medium High Glucose supplemented with 15% fetal bovine serum, 2 mM [l]{.smallcaps}-glutamine, 50 U/ml penicillin, 50 µg/ml streptomycin, 0.1 mM non-essential amino acids (all from GIBCO), 0.1 mM 2-mercaptoethanol (Sigma) and 1000 U/ml LIF\]. ES cells were maintained at 37°C, 5% carbon dioxide, fed with fresh media daily, and transferred to new plates after trypsinization.

Chromatin immunoprecipitation
-----------------------------

Typically (150--200) × 10^6^ cells were collected for each ChIP experiment. The cellular proteins and DNA were cross-linked by the addition of formaldehyde (0.4% final concentration). The plates were incubated for 10 min at room temperature and then the reaction was stopped by the addition of glycine (0.125 M final concentration). The cells were washed twice with 10 ml chilled phosphate buffered saline (PBS). Each plate was scraped with 2 ml PBS with protease inhibitors (Roche complete, 10 mM PMSF dissolved in ethanol), pelleted by centrifugation at 2500 rpm and resuspended in 1 ml per dish of FA/SDS buffer (50 mM Tris--HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS) with protease inhibitors and incubated on ice for 15 min. The subsequent operations were performed at 4°C. Chromatin was collected by centrifugation for 20 min at 12 000 rpm, resuspended in the same amount of FA/SDS and put on a rotating wheel for 1 h, centrifuged and resuspended in 0.4 volume of FA/SDS with protease inhibitors. The 400 µl batches of chromatin were fragmented with a sonicator (Diagenode) to generate DNA fragments of 300--400 bp mean size. The chromatin was collected by centrifugation at 14 000 rpm for 10 min and was kept at −80°C until needed.

The immunoglobulin-coupled magnetic beads (Dynal) used in the chromatin immunoprecipitation experiments were prepared essentially as described previously ([@gkr737-B40]). Anti-HA antibody was HA7 H-3663 (Sigma) and anti-Flag anti-body was F-1804 (Sigma). For each ChIP experiment, 240 µg DNA (RPC1, RPC4, 46C) or 750 µg DNA (BRF1, BRF2) of sonicated chromatin were incubated with 150 µl beads for 2 h at room temperature. The beads were magnetically pelleted and the supernatant was removed. The beads were washed with 1 ml of low salt buffer (pH 8.0, 20 mM Tris--HCl, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100, 0.1% SDS), then with the same volume of high salt buffer (pH 8.0, 20 mM Tris--HCl, 2 mM EDTA, 500 mM NaCl, 1% Triton X-100, 0.1% SDS), then with low LiCl buffer (pH 8.0, 10 mM Tris--HCl, 1 mM EDTA, 250 mM LiCl, 1% NP-40, 1% deoxycholate) and finally twice with TE buffer (pH 8.0, 10 mM Tris--HCl, 1 mM EDTA). The first ChIP was performed using the anti-HA antibody. The bound chromatin was eluted using FA/SDS buffer containing the HA peptide (0.5 mg/ml; Ansynth Service) for 4 h at 16°C then overnight at 4°C. For the second ChIP, the supernatant was incubated with 50 µl beads coupled to anti-Flag antibodies which were treated as above except for the elution that was performed by incubation with a buffer containing 1% SDS and 0.1 M NaHCO~3~. Reversal of the cross-links and DNA purification were performed as described previously ([@gkr737-B41]). TFIIIC subunits and TCEA1 ChIPs were fragmented using MNase I. The protocol will be described in detail elsewhere (M. Gérard, manuscript in preparation).

The immunoprecipitated DNA was analyzed by quantitative real time PCR on an ABI Prism 7000 or 7300 machine (Applied Biosystem; 40). Relative quantification using a standard curve method was performed and the occupancy level for a specific fragment was defined as the ratio of immunoprecipitated DNA over total DNA.

Sequencing of the immunoprecipitated DNA and analysis of the regions bound by the RNA pol III
---------------------------------------------------------------------------------------------

For each chromatin immunoprecipitation, the DNA was sequenced on a single Solexa genome analyzer GS or GA IIx channel using the procedures recommended by the manufacturer (Illumina). The characteristics of each sequencing experiment are indicated in [Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1). The bound regions were identified using Quest version 2.3 ([@gkr737-B42]) and an in-house program that used Quest method for peak calling. The data have been deposited to the ArrayExpress database under accession number E-MTAB-767.

RNA preparation
---------------

Total RNAs were isolated from 46C wild-type ES cells, using 1 ml of Trizol (Invitrogen) per 10 cm-dish, as indicated by the manufacturer. Total RNAs were prepared following the manufacturer\'s protocol, except that the RNA pellet were washed with 80% ethanol, without shaking. The RNAs were suspended in diethylpyrocarbonate treated water, at around 2 mg/ml and stored at −80°C until needed. Integrity of RNA was tested on 1.5% agarose gel. Total RNA concentration and purity were verified using a NanoDrop spectrophotometer ND-1000 (Thermo Scientific), measuring absorbance at OD 260/280. Total RNA samples were treated with 1 U of RQ1 DNase (Promega) per µg of RNA, for 1 h at 37°C. DNase was inactivated by the addition of 20 mM ethylene glycol tetraacetic acid, pH 8.0 (Stop solution) and heated at 65°C for 10 min. The RNA was then precipitated with isopropanol.

cDNA synthesis
--------------

cDNA synthesis was performed using SuperScript II reverse transcriptase with random hexamer primers (Invitrogen) according to the manufacturer\'s instructions. In brief, 5 μg of total RNA, 2 μl of random hexamer primers (10 μM), 1 μl of dNTP mix (5 mM each) to 11 µl in total, were incubated at 65°C for 5 min. After chilling on ice for 2--3 min and brief centrifugation, 5 μl of first-strand synthesis buffer (5×, containing 250 mM Tris--HCl \[pH 8.3\], 375 mM KCl, 15 mM MgCl2), 2 μl of 0.1 M DTT, were added and the tubes were incubated at 25°C for 1 min. Then, 1 μl of (200 U/μl) of SuperScript II reverse transcriptase was added and the reaction was first incubated at 25°C for 10 min, followed by incubation at 42°C for 1 h. Reverse transcriptase activity was terminated by incubation at 70°C for 15 min. 1 µl RNase H (Invitrogen, 2U/µl) was added and further incubated at 37°C for 20 min. Samples were stored at −20°C until needed. The cDNA solution was diluted 10-fold before use in reverse transcriptase-PCR (RT--PCR). PCR were performed using specific primers covering the region of interest. The reactions contained 25 ng of cDNA, and primers at a final concentration of 150 nM. RT-PCR reactions were analyzed by gel electrophoresis. Further, total RNA samples were analyzed for the possible presence of DNA contamination by PCR using RNA not reverse-transcribed.

RESULTS
=======

Setting up a high-specificity tandem affinity chromatin immunoprecipitation method in mouse ES cells
----------------------------------------------------------------------------------------------------

To identify the regions bound by the Pol III transcription machinery, we developed a tandem affinity chromatin immunoprecipitation method in mouse ES cells. Two different specific subunits of Pol III, RPC1 and RPC4, the BRF1 and BRF2 subunits of TFIIIB-β or TFIIIB-α, respectively and the TFIIIC220, TFIIIC110 and TFIIIC90 subunits of TFIIIC were tagged ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). To investigate whether or not TFIIS is a Pol III transcription factor, TCEA1 was also tagged. We introduced a cassette encoding consecutively six histidines, one Flag and one HA epitope just after the last sense codon of the Pol III, BRF and TFIIIC genes. A neomycin marker flanked by loxP sites follows the tag cassette. The construction was introduced in 46C mouse ES cell genome using the recombineering method ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1) and [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)) ([@gkr737-B37]). The neomycin marker was removed by expressing the cre recombinase. The correct integration of the cassette at the endogenous locus and the excision of the neomycin marker were verified by Southern blotting and PCR. The expression and correct size of the C-terminally tagged proteins were verified by western blotting with a monoclonal anti-HA antibody ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)).

Chromatin from the RPC1-, RPC4-, BRF1- or BRF2-tagged ES cell lines was prepared. ChIP experiments in RPC1 or RPC4 ES lines with anti-HA antibodies enriched strongly a tRNA-val gene and the H1 gene (from 40- to 110-fold) but not the ARBP gene, which is transcribed by Pol II ([Figure 1](#gkr737-F1){ref-type="fig"}A). We then tested whether genes that depend on BRF1 or BRF2 could be distinguished. BRF1 ChIP enriched specifically two tRNA genes. Conversely, BRF2, but not BRF1, was associated with H1 gene, encoding the RNA subunit of the RNase P, and U6 ([Figure 1](#gkr737-F1){ref-type="fig"}B) ([@gkr737-B5],[@gkr737-B6]). Figure 1.Chromatin immunoprecipitation of the Pol III transcription machinery in mouse ES cell lines. ChIP experiments were performed with the HA7 H-3663 anti-HA antibody (**A** and **B**) as described in 'Materials and Methods' section. (A) Chromatin extracts from RPC1 or RPC4 cell lines were used to show Pol III enrichment on different types of class III genes but not on the ARBP class II gene. (B) Extracts from BRF1 or BRF2 cell lines were used to demonstrate specific enrichment of TFIIIB-β or TFIIIB-α on genes with type 2 (tRNAs) or type 3 promoters (H1, U6), respectively. An untagged cell line was used as a negative control. (**C**) Tandem ChIPs improved signal to noise ratios. Single round ChIP (RPC4 single IP) were performed as above with HA7 H-3663 anti-HA antibody and were compared with experiments in which a second round (RPC4 tandem IP) of immunoprecipitation was done with F-1804 anti-Flag antibody after elution of proteins with an HA peptide. Enrichment-folds of sequences from an RPC4 ES cell line chromatin extract relative to an untagged cell line chromatin are indicated.

To improve the specificity of the ChIP experiments, tandem immunoprecipitations were performed. The chromatin was first ChIPed with the anti-HA antibody as above, and then eluted by competition with an HA peptide. The enriched chromatin was submitted to a second round of ChIP with a monoclonal anti-Flag antibody. The second ChIP further improved the enrichment ratio above background up to 8-fold depending on the protein and gene considered ([Figure 1](#gkr737-F1){ref-type="fig"}C and [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). The protocol used here is thus, highly specific for ChIP experiments of tagged proteins expressed from their native locus in mouse ES cells. It is also generic since it does not depend on the generation of high specificity antibodies.

Analysis of the regions bound by RNA polymerase III
---------------------------------------------------

DNA from the chromatin associated with Pol III was sequenced using a Solexa Genome Analyzer. The comparison of ChIP-Seq experiments using tagged RPC1 and RPC4 ES cell lines allowed us to cross-validate the Pol III-binding sites. We considered as bound regions, only those that showed co-occupancy by RPC1 and RPC4. These regions were validated if the number of tags mapping within the defined interval in the ChIP-Seq experiments with RPC1 and RPC4 were both 5-fold higher than in the untagged ES cell line, which was used as a negative control. Regions that satisfied only one of the two conditions were visually inspected using the UCSC genome browser and rejected if the 46C track showed a high background around the bound region. The protein-bound regions were annotated using the mm9 UCSC mouse database. The regions that were associated with more than one annotation were visually inspected and eventually split to associate one region with each annotation. If one annotation was associated with two or more regions, these were inspected and eventually fused. [Figure 2](#gkr737-F2){ref-type="fig"} and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1) show examples of tag density profiles on various regions representative of several class III genes. Data concerning the bound regions can be found in [Supplementary Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1). Figure 2.Representative examples of sequence reads that map on bound regions. (**A**) Binding of Pol III and BRF1 to two tRNA genes and a SINE. The sequences that map to chromosome 11 are displayed using the UCSC genome browser. A 1 kb scale is shown at the top of the Figure. The sequence tags are represented by colored rectangles. Tags identified in the ChIP-Seq experiments performed with the RPC1-tagged, RPC4-tagged, BRF1-tagged or BRF2-tagged ES cell lines and 46C negative control cell line are colored in blue, yellow, red, green and gray, respectively. Light colors indicate the sequences that match the top strand. Dark colors indicate the tags that match the bottom strand. The location of repeated sequences, according to RepBase, is indicated at the bottom of the Figure by gray or black boxes. The two black boxes refer to two tRNA-Cys-TGY genes. The bound SINE is a PB1D7 repeat of the Alu family. (**B**) Binding of Pol III transcription machinery to an unannotated region on chromosome 3.

### tRNAs

A total of 284 tRNA genes were bound by Pol III, including one selenocysteine tRNA gene and one possible suppressor. Of these, 271 were predicted by Coughlin *et al*. ([@gkr737-B43]) and 281 by the Genomic tRNA Database (GtRNADb). Coughlin *et al*. predict that 461 tRNA genes exist based on the sequence of the expressed tRNAs. GtRNADb, which relies upon the tRNAscan-SE program ([@gkr737-B44]), predicts the existence of 433 tRNA genes (including two selenocysteine tRNAs and one possible suppressor) in the mouse genome. Altogether, 526 tRNAs are annotated on the mouse genome by these two databases. Totally, 59 and 65% of the genes predicted by Coughlin *et al*. and GtRNADb, respectively, were bound by Pol III in mouse ES cells. This observation raised the possibility that some tRNAs were not detected because they cannot be identified by unique tags. The percentage of nucleotides that could not be mapped (NM score) within 150 nt on either side or within the tRNA genes that were actually bound by Pol III was computed. For each tRNA, we considered the lowest NM score from the three regions. We found that the worst NM score for a bound tRNA was 75%. We figured out that among the 242 tRNA genes predicted by Coughlin *et al*. or GtRNAdb that were not bound by Pol III, only 14 had an NM score \>75%. Hence, we did not underestimate the number of bound tRNA genes by \>13.2%. We performed independent ChIP experiments for three bound tRNA genes and two mappable unbound tRNA genes, which agreed with the ChIP-Seq experiments ([Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). The genomic distribution of bound tRNA genes and other class III genes is shown in [Supplementary Figure S6](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1).

### snRNAs

In addition to tRNA genes, we also found binding of Pol III transcription machinery on the U6, 5S, 7SK, 7SL, 4.5S, BC1, HY1 and HY3 genes. However, the number of bound genes was very small compared to that predicted in Repbase ([Table 1](#gkr737-T1){ref-type="table"}). For example, Repbase predicts 1269 U6 genes and Ensembl, 617 when we actually found only 5 that were bound. As for the tRNA genes, we performed an independent ChIP experiment and verified for two genes of each 7SL, 7SK, U6 and HY3, one bound in the ChIP-Seq experiment and one mappable but unbound, that Pol III was present or not as expected ([Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). Table 1.Pol III-associated regionsRNANumber boundNumber predicted[^a^](#gkr737-TF1){ref-type="table-fn"}Percent boundtRNA28452653.84.5S1314750.815S39840.307SK16650.157SL22760.72BC1263510.03HY11372.70HY31156.67HY4020.00HY5010.00U6512690.39[^6]

### New Pol III transcripts

About 30 regions were bound by both RPC1 and RPC4, but were not annotated as Pol III-transcribed genes or SINEs and could thus correspond to new Pol III transcripts. Of note, these regions were neither annotated as transcribed by Pol II, nor corresponded to miRNAs. We verified by an independent ChIP experiment for nine of those regions that they were indeed bound by RPC1 and RPC4 ([Supplementary Figure S7A](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). Furthermore, we looked for the presence of an RNA associated with the Pol III-bound region by RT--PCR ([Supplementary Figure S7B](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). An RNA was transcribed from 16 regions out of the 18 that were examined. Most of these regions were conserved in the rat genome but only one was highly conserved in human ([Supplementary Figure S7C](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1) and [Supplementary Table S5](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). The latter region, which was also associated with Pol III in human, had a typical organization for class III genes with conserved A-box and B-box and terminator. Altogether, these results strongly suggest that we have identified new class III transcripts.

Distribution of BRF1 and BRF2 on class III genes
------------------------------------------------

We also tagged the BRF1 or BRF2 subunits of TFIIIB-β or TFIIIB-α, respectively, to investigate which genes depend on either form of the Pol III factor. Type I and II promoters require the presence of BRF1 in TFIIIB-β transcription factor for their transcription while type III uses BRF2 as a subunit of TFIIIB-α. As expected, BRF1 was exclusively associated with types I and II promoters ([Figures 2](#gkr737-F2){ref-type="fig"}A and [3](#gkr737-F3){ref-type="fig"}A--C), whereas, BRF2 was bound to type III promoters only ([Figure 3](#gkr737-F3){ref-type="fig"}D and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)), indicating that no class III gene could use both TFIIIB variant. BRF2 was associated with a small number of snRNAs that included U6, 7SK, the H1 and MRP RNA genes, U6atac, the tRNA^sec^ and two of the Y RNA genes, HY1 and HY3. Apart from these genes that were already predicted to depend on BRF2, no new region was found. The new genes were associated with low, or sometimes background levels of BRF1 ([Figure 3](#gkr737-F3){ref-type="fig"}E). This situation probably stems from the fact that the number of tags associated with the new genes is often low even for the Pol III ChIP. The number of tags associated with class III genes in experiments with the BRF1 cell line is around 10-fold smaller than with the RPC4 cell line ([Supplementary Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1), compare RPC4.SUM_DENSITY to BRF1.SUM_DENSITY). A thorough assessment of BRF1 and/or BRF2 presence on the new genes would thus require a 10-fold deeper sequencing. Figure 3.Distribution of Pol III, TBP, BRF1 and BRF2 relative to class III genes. Tag densities are shown for RPC1, RPC4, BRF1, BRF2 and TBP ([@gkr737-B45]) relative to the location of the RNA 5′-end for (**A**) tRNA genes, (**B**) unbound tRNA genes, (**C**) SINEs, (**D**) BRF2-associated genes and (**E**) new class III genes. For these, neither the transcription orientation, nor the TSS or end is known. Hence, the distribution is shown relative to the RPC4 density peak.

We wondered where the two forms of TFIIIB were positioned, relative to the mature RNA 5′-end (the TSS of mouse class III genes have not been systematically determined). On tRNA genes, BRF1 peak density was located 10 nt upstream of RNA 5′-ends ([Figure 3](#gkr737-F3){ref-type="fig"}A), which is within a few nucleotides of the position determined by *in vitro* footprinting experiments. A similar situation was found for BRF2 on genes with type III promoters with a peak of tag density located 14 nt upstream RNA 5′-ends ([Figure 3](#gkr737-F3){ref-type="fig"}D). Using data from Kagey *et al*. ([@gkr737-B45]), we also looked at the distribution of TBP relative to the class III genes. TBP was positioned 17 or 12 nt upstream of RNA 5′-ends for class II or class III promoters, respectively.

Transcription of SINEs
----------------------

Pol III *in vitro* transcription systems can drive the transcription of SINEs ([@gkr737-B4]). We wondered whether some of the SINEs could be bound by Pol III, and thus most probably be transcribed *in vivo*. Indeed, we found 241 locations on the mouse genome that were associated with both RPC1 and RPC4 and had a SINE annotation according to Repeatmasker. We first looked at the distribution of the sequence divergence of the SINEs ([Supplementary Figure S8A](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). The distribution is bi-modal with maxima at 7 and 27% divergence and a minimum at 13%. The SINEs were separated in two classes according to their divergence using 13% as threshold. Notably, most (80**%**) of the bound SINEs belonged to the highly conserved category ([Supplementary Figure S8B](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)).

We wondered if the small number of observed bound SINEs in our ChIP-Seq experiments could stem from the low mappability of the regions encompassing the SINEs. To answer this question, we used an approach that was similar to the one applied to the tRNA genes. The bound SINEs were divided in two populations depending on whether their divergence was ≥13%. We determined the lowest NM score for bound SINEs of each category. The worst NM score within the SINE or the 150 nt flanking-regions was 65% for the conserved category and 50% for the diverged category. We then computed the NM score for all the SINEs predicted by Repeatmasker for each of the two divergence classes and determined the number of SINEs present in the mouse genome that had their two flanking regions with NM scores above those observed in bound SINEs. We postulated that the proportion of bound SINEs in the non-mappable population was similar to that in the mappable population. We could thus estimate that only around 10 non-mappable SINEs might be bound.

We searched in the bound SINEs for the presence of the TRGYTYARTGG and GTTCRAWTC sequences, which correspond to the A- and B-boxes in human ([@gkr737-B30]). Of them, 64% contained an A-box and 87% a B-box (at *P*-value 10^−3^), indicating that most of them had highly conserved type II promoters. Pol III-associated SINEs were found throughout the mouse genome and were not particularly associated with other categories of class III genes ([Supplementary Figure S6B](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). Altogether, these observations indicate that a limited set of the SINEs direct Pol III transcription *in vivo*.

Chromatin environment of class III genes
----------------------------------------

We looked for the presence of various chromatin marks around the bound and unbound class III genes, comparing the distribution of H3K4me1, -me2, -me3, which are considered as active chromatin marks, and H3K27me3, that is an inactive chromatin mark ([@gkr737-B46; @gkr737-B47; @gkr737-B48]). We also analyzed the distribution of H3K9me3, which are deposited at many euchromatic loci in mouse ES cells ([@gkr737-B49]). Interestingly, both Pol III bound tRNA genes and BRF2-dependent genes were surrounded by peaks of H3K4me3 located around 400 nt on either side of the RNA 5′-ends ([Supplementary Figure S9](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)). H3K4me3 mark was absent from unbound tRNA genes (data not shown). The euchromatic mark H3K9me3 might be slightly enriched on either side of active class III genes. On the contrary, H3K27me3, which is typically heterochromatic was completely absent. This pattern is extremely similar to that of Pol II-transcribed genes.

Distribution of TFIIIC
----------------------

TFIIIC is required for the transcription of class III genes that are under the control of types I and II promoters, i.e. 5S and tRNA genes. However, in *S. pombe*, *S. cerevisiae* and human, TFIIIC binds some regions independently of Pol III ([@gkr737-B26],[@gkr737-B30],[@gkr737-B31],[@gkr737-B35]). We explored the genome-wide distribution of TFIIIC in mouse ES cell lines where one subunit of TFIIIC, TFIIIC220, −110 or −90, was tagged. Since the standard ChIP protocol that used sonication for DNA shearing did not give satisfactory results, it was modified by the inclusion of a MNase I DNA digestion step (M.G., manuscript in preparation). Tandem ChIP experiments allowed the identification of 2652 regions that were considered as bound since they were consistently enriched in ChIP experiments with the three TFIIIC-tagged cell lines but not in an untagged control cell line ([Supplementary Table S6](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)).

Of the 283 tRNA genes bound by Pol III (excluding the selenocysteine tRNA which has a type III promoter), 261 were also associated with significant levels of all three TFIIIC subunits. The three subunits displayed similar distributions downstream of BRF1 on the body of the tRNA genes ([Figure 4](#gkr737-F4){ref-type="fig"}A). The distribution of the tags on tRNA genes was very similar for the three subunits tested, showing an extended association with tRNA genes. TFIIIC was absent from the tRNA genes that were not bound by Pol III or BRF1 (data not shown). In line with their promoter organization, Pol III-bound SINEs were also associated with TFIIIC and BRF1, but not BRF2 ([Figure 4](#gkr737-F4){ref-type="fig"}B). As expected from previous *in vitro* experiments ([@gkr737-B5]), the BRF2-associated genes were completely devoid of TFIIIC ([Figure 4](#gkr737-F4){ref-type="fig"}C). Interestingly, the three TFIIIC subunits were generally associated with the new class III genes while no BRF2 could be found suggesting that they depend on TFIIIC for their transcription ([Figure 4](#gkr737-F4){ref-type="fig"}D). Figure 4.Distribution of TFIIIC relative to class III genes. Tag densities are shown for TFIIIC220, −110, −90, BRF1 and BRF2 relative to the location of the RNA 5′-end for (**A**) tRNA, (**B**) SINEs, (**C**) BRF2-associated. For the new class III genes (**D**) the distribution is shown relative to the RPC4 density peak.

Several recent studies pointed at the presence in human cell lines of numerous ETC loci where TFIIIC is present but devoid of Pol III or TFIIIB-α or -β ([@gkr737-B26],[@gkr737-B30],[@gkr737-B31],[@gkr737-B35]). Similarly, 2233 ETC loci bound by the three TFIIIC subunits were detected by our ChIP-Seq experiments. TFIIIC has been shown to play a role in the organization of chromatin in *S. cerevisiae* and *S. pombe* and to act as a barrier in the extension of heterochromatin into euchromatic territories ([@gkr737-B35],[@gkr737-B50],[@gkr737-B51]). It has been shown that CTCF protein plays a similar insulator role in mammals ([@gkr737-B36]). Moreover, CTCF interacts with cohesins to position it at many sites ([@gkr737-B52]). A correlation between CTCF and ETC sites in human cells has been found ([@gkr737-B30],[@gkr737-B31]). To investigate the potential correlation between the ETCs- and CTCF-binding sites in mouse ES cells, the ETCs were ordered according to their distance relative to the CTCF-binding sites (data taken from ref. 53). In parallel, an identical number of randomly selected regions were ordered using the CTCF-binding site distance criterion. Heat maps of the tag density for TFIIIC220 and CTCF were generated ([Figure 5](#gkr737-F5){ref-type="fig"}A) and compared with the heat maps of the randomly selected regions ([Figure 5](#gkr737-F5){ref-type="fig"}B). In agreement with the observations made in human cells, we found that 85% of ETCs also had CTCF-binding sites within 20 kb ([Figure 5](#gkr737-F5){ref-type="fig"}A). The distribution of CTCF was clearly different when regions were selected randomly ([Figure 5](#gkr737-F5){ref-type="fig"}B; compare the sigmoid curves in the two panels). The CTCF-binding sites were previously shown to be associated with the Smc1A and Smc3 subunits of cohesin ([@gkr737-B45]). Heat maps were drawn for Smc1 and Smc3 and confirmed the clear co-occupancy of these proteins with CTCF. Intriguingly, in addition to being closely associated with CTCF, we observed that Smc1A and, to a lesser extent, Smc3 were enriched at the ETCs themselves, as indicated by the increased tag density centered on the ETCs ([Figure 5](#gkr737-F5){ref-type="fig"}A) which is absent from the maps of the randomly selected regions ([Figure 5](#gkr737-F5){ref-type="fig"}B). Figure 5.Distribution of CTCF, Smc1a, Smc3 relative to ETC-bound TFIIIC220. (**A**) Distribution of CTFC, Smc1a and Smc3, relative to TFIIIC220. The ETC regions bound by TFIIIC220 (C220) were ordered relative to their distance to CTFC-binding sites using seqMINER ([@gkr737-B63]). The windows span 20 kb upstream and downstream the center of TFIIIC bound regions. The distribution of Smc1a and Smc3 on the same regions is shown on the two right panels according to the same order. (**B**) Distribution of CTCF, Smc1a and Smc3 relative to randomly selected regions. Randomly selected regions were sorted according to the distance of CTCF-binding site to the center of the region. Smc1a- and Smc3-binding sites are shown according to the same in the two right panels.

Enrichment of TCEA1 isoform of TFIIS at class II and class III genes
--------------------------------------------------------------------

TFIIS is a transcription elongation factor that stimulates Pol II transcription elongation and initiation. Moreover, we have shown that it acts positively on Pol III transcription in *S. cerevisiae* ([@gkr737-B22]). The distribution of TFIIS on the genome of mouse ES cells was thus investigated. Three variants of TFIIS are encoded by the mouse genome. The ubiquitously expressed variant TCEA1 was tagged at its N-terminus because C-terminal tagging abolishes TFIIS function in yeast. Chromatin immunoprecipitation was performed using the same protocol that was used for TFIIIC.

We found that 57.6% of the tRNA genes and 50% of the BRF2-dependent genes that were associated with Pol III were also bound by TCEA1 ([Figure 6](#gkr737-F6){ref-type="fig"} and [Supplementary Figure S10](http://nar.oxfordjournals.org/cgi/content/full/gkr737/DC1)) using a 3-fold signal to background threshold. About 41.1% of the bound SINEs and 16.7% of the new class-III genes were also bound by TCEA1 using the same criterion. We wondered if the presence of TCEA1 on class III genes does require Pol II (data from ref. 54). On tRNA genes and active SINEs, only very low levels of hypophosphorylated Pol II is found upstream of the genes ([Figure 6](#gkr737-F6){ref-type="fig"}A and B). Low levels of hypophosphorylated Pol II was also present downstream of the SINEs. Pol II phosphorylated on serine 2, 5 or 7 of the CTD was not significantly enriched on the regions surrounding active tRNA genes or SINEs. The distribution of TCEA1 on tRNAs and SINEs resembled that of Pol III but was shifted upstream toward the 5′-end in line with its possible role in transcription initiation by Pol III ([@gkr737-B22]). Intriguingly, the hypophosphorylated, S7P and S5P forms of Pol II were all significantly present upstream of BRF2-associated genes ([Figure 6](#gkr737-F6){ref-type="fig"}C). The level of unphosphorylated Pol II was around 5-fold more abundant on BRF2-associated genes, than on active tRNA genes. However, two peaks of TCEA1 were found on BRF2-dependent genes, one associated with Pol II, the other with Pol III. These observations suggest that TFIIS plays a role in Pol III transcription. Figure 6.Distribution of TCEA1 and Pol II relative to class III genes. Tag densities for RPC4, TCEA1 (this work) and the hypophosphorylated (RNAPII) ([@gkr737-B64]), serine 2 (RNAPII_S2P) ([@gkr737-B54]), serine 5 (RNAPII_S5P) and serine 7 (RNAPII_S7P) phosphorylated forms of Pol II, are shown relative to the location of the RNA 5′-end for bound (**A**) tRNA, (**B**) SINEs and (**C**) BRF2-associated genes. The tag density scale for RPC4 is indicated on the right side of the plots.

The distribution of TCEA1 on class II genes was also analyzed. When ordered according to RNA steady-state levels transcribed from a given gene (measured by RNA-seq; C. Keime and M. Gérard, manuscript in preparation), Pol II and TCEA1 distributions were similar ([Figure 7](#gkr737-F7){ref-type="fig"}). Indeed for the 10 000 most highly expressed genes, the Spearman correlation coefficient between Pol II and TCEA1 occupancies on class II genes was 0.77. A large fraction of the genes, active or inactive, have paused Pol II just after the TSS. We wondered if TCEA1 occupancy might correlate with the transition from pausing to elongation. This is not the case since the levels of Pol II and TCEA1 on the pausing regions (defined here as the 300 bp after the TSS) of actively transcribed or non-productive genes with paused Pol II were similar, with Spearman correlation coefficient of 0.59 and 0.54, respectively (see [Figure 7](#gkr737-F7){ref-type="fig"}B and C for examples of Pol II and TCEA1 distributions). The Spearman correlation coefficient between TCEA1 and Pol II occupancies downstream of the pausing region were 0.75 and 0.76, respectively, for the two classes of genes. Figure 7.Distribution of TCEA1 on class II genes. (**A**) Hypophosphorylated Pol II (RNAPII) and TCEA1 have similar distribution on genes. The distribution of Pol II, S5P Pol II and TCEA1 5 kb upstream and downstream of the TSS is plotted for the 10 000 most expressed genes in ES cells based on RNA-Seq (M.G., manuscript in preparation). The genes were ordered according to their expression levels using seqMINER. (**B**) Examples of Pol II and TCEA1 profiles on highly transcribed genes. TTS: Transcription termination site. (**C**) Examples of Pol II and TCEA1 profiles on paused unproductive genes.

DISCUSSION
==========

The genome-wide distribution of Pol III, TFIIIB-β, its variant form TFIIIB-α and TFIIIC has been established in mouse ES cells using a highly specific ChIP-Seq procedure. Only 284 tRNA genes out of 526 predicted genes were indeed associated with Pol III and, hence, were likely to be transcribed. The fact that Pol III was found only on a very small number of SINEs suggests that mechanisms exist to prevent their transcription. Additionally, 30 sites on the mouse genome were associated with Pol III, but lacked any annotation, most of them being transcribed. The regions encoding the new transcripts were usually conserved in the rat genome but except in one case, this conservation did not extend to man. The chromatin environment of class III genes resembles strongly that of class II genes with high levels of H3K4me3 upstream and downstream of the gene and low levels around the transcription start site. Studies in human have indicated that Pol II is associated with class III transcription ([@gkr737-B29],[@gkr737-B30],[@gkr737-B32]). However, we found different situations depending on whether we looked at BRF1- or BRF2-associated genes. Upstream of tRNA genes, only very low levels of hypophosphorylated Pol II were observed. On the contrary, Pol II was present upstream of BRF2- associated genes. Finally, we observed that TCEA1 isoform of TFIIS was associated with classes II and III genes. The distribution pattern of TCEA1 suggests that it is not sufficient to stimulate the transition of paused Pol II into elongation. Moreover, it indicates that TFIIS could, as in yeast, be a Pol III general transcription factor.

Thanks to our highly specific tandem ChIP-Seq protocol and cross-validation by experiments that investigated independently the distribution of several subunits belonging to Pol III or TFIIIC, the mouse Pol III transcriptome is now precisely defined. As in human cell lines ([@gkr737-B29; @gkr737-B30; @gkr737-B31; @gkr737-B32; @gkr737-B33]), the Pol III transcription machinery is associated with only a subset of the tRNA genes. This situation also holds true for the BRF2-associated genes. We estimated that \<5% of the tRNA genes might have escaped our analysis. A total of 30 unannotated regions were associated with significant levels of Pol III. Several arguments indicate that they are indeed transcribed by Pol III. First, we could verify the presence of Pol III in independent experiments. Second, in addition to Pol III, most of these regions were associated with TBP and TFIIIC. In contrast, BRF2 was present only on regions that were already known to require TFIIIB-α for their transcription *in vitro*. Third, an RNA was found in \>80% of the new regions that we tested. Finally, none of these regions was annotated. Experiments have suggested that a small number of miRNAs is transcribed by Pol III in human ([@gkr737-B55],[@gkr737-B56]). This view was later challenged by other experiments ([@gkr737-B57]). In mouse ES cells, none of the newly identified regions overlapped with miRNA annotations suggesting that the transcription of this class of RNA by Pol III is very limited. The function, if any, of the RNA transcribed from the new Pol III-associated regions will await further studies.

*In vitro* transcription experiments have demonstrated that Pol III is able to transcribe the SINEs ([@gkr737-B4]). It is also known that SINEs, which number in hundreds of thousands in mammalian genomes, result from the insertion of retrotranscribed Pol III transcripts ([@gkr737-B3]). We thus wondered if we could estimate how many of them are indeed associated with the Pol III transcription machinery. Unexpectedly, only 241 SINEs were bound, usually at rather low levels compared with tRNAs. The transcribed SINEs were distributed throughout the genome independently of tRNA or other class III genes. The small number of transcribed SINEs suggests that a general mechanism might repress their expression. This situation might, however, be specific to ES cells.

In human cells, class II genes are closely associated with class III genes. Pol II transcribed genes are often present upstream of class III genes ([@gkr737-B29; @gkr737-B30; @gkr737-B31; @gkr737-B32]). Even though Pol II transcription inhibition has only a modest effect on the transcription of adjacent class III genes, it has been argued that Pol II might regulate Pol III transcription ([@gkr737-B32]). Our observations in mouse indicated that, at actively transcribed tRNA genes, the level of Pol II is extremely low. Moreover, while the hypophosphorylated non-elongating form of Pol II was present upstream of the bound tRNA genes at very low levels, the other forms were virtually absent. In contrast, hypophosphorylated, S7P and S5P Pol II were all present upstream of BRF2-associated genes. This observation suggests that, in mouse, the chromatin organization around transcribed tRNA genes, allows low levels of hypophosphorylated Pol II to bind but prevents the transition to elongation. On the other hand, the promoters of BRF2-associated genes, which are gene external and resemble those of Pol II transcribed genes, would allow the association of class II transcription machinery and divergent transcription relative to Pol III. The observation of different behaviors for tRNA genes and BRF2-associated genes strongly suggests that, on tRNA genes, Pol II presence has probably limited functional significance in mouse. Type III promoters are gene external and their transcription by Pol III is determined by the presence of a TATA box which, if absent, leads to transcription by Pol II ([@gkr737-B58],[@gkr737-B59]). It has also been shown that U6 transcription is decreased \~2-fold in human cell lines when Pol II transcription is inhibited ([@gkr737-B60]). It is thus possible that, as in human, the presence of Pol II upstream of BRF2-associated genes in mouse might stimulate their transcription by Pol III.

The binding pattern of TFIIIC was clearly distinct from that of Pol III. Whereas the factor was present on tRNA genes and on the new Pol III-associated regions, more than 2200 TFIIIC-binding sites were located far away from class III genes. This number is similar to that of the ETC loci in K562 human cells where 1865 such sites were found ([@gkr737-B31]). The ETC sites have first been detected in *S. cerevisiae* and *S. pombe* and have been shown to play a role in the organization of chromatin ([@gkr737-B26],[@gkr737-B35],[@gkr737-B51]). Even though the ChIP-Seq experiments were performed with different protocols, antibodies and in different cell lines, the ETC site number in human is remarkably similar to that found in mouse, both organisms having comparably sized genomes (3.1 Gb and 2.9 Gb for man and mouse, respectively). CTCF has been shown to have an enhancer-blocking activity ([@gkr737-B36]). In mouse ES cell lines, CTCF is loosely associated with ETC loci, a relationship that might be indicative of an interdependence and/or common role in silencing transcription of adjacent sequences. Cohesins are required for the localization of CTCF at boundary elements ([@gkr737-B52]). In line with previous observations, in mouse and human, Smc1a and Smc3 distributions closely follow that of CTCF. Remarkably, Smc1a and Smc3 were also present on the TFIIIC peak. In *S. cerevisiae* mutations in Smc1 or Smc3 affects the boundary function of tRNA genes ([@gkr737-B35],[@gkr737-B50],[@gkr737-B51]). Moreover, a recent report has shown that cohesins connect enhancers and promoters through DNA loops via interactions with the Mediator, stimulating Pol II transcription ([@gkr737-B45]). These observations raise the intriguing possibility that the presence of cohesins at ETCs and CTFC-binding sites might stimulate the formation of DNA loops, promoting an enhancer-blocking activity of TFIIIC and shape the organization of chromatin.

In *S. cerevisiae*, we showed that TFIIS occupies nearly all class III genes. In addition, some TFIIS mutations specifically affect Pol II or Pol III transcription *in vitro* and *in vivo* demonstrating that TFIIS plays a key role in Pol III transcription in yeast ([@gkr737-B22]). The observation that, in mouse ES cells, TCEA1 is associated with the majority of class III genes independently of Pol II, strongly suggests that TFIIS is also a Pol III transcription factor in mammals. Intriguingly, its distribution on class III genes is skewed toward the TSS when compared to that of Pol III, in line with a putative role in transcription initiation as we proposed in yeast.

Previous studies in *Drosophila* have shown that TFIIS plays a role in stimulating paused Pol II to enter active elongation ([@gkr737-B61],[@gkr737-B62]), a situation that could also hold in mouse ES cells. We wondered if the presence or absence of TFIIS could be related to pausing on class II genes. TFIIS occupancy on class II genes followed that of Pol II both on elongating genes and on non-productive genes that have high levels of paused Pol II, indicating that the pause is not the consequence of the absence of TFIIS. Our observations thus raise the intriguing possibility that TFIIS activity, but not its recruitment, might be somehow stimulated upon the entry into elongation.

In summary, this study provides a high-resolution map of class III genes active in mouse ES cells and it shows that the TFIIIC transcription factor is present at around 2000 sites on the genome independently of Pol III and its other factors TFIIIB-α or -β, possibly playing a role in chromatin organization. Finally, we provide evidence that support a role for TFIIS Pol II elongation factor in class III transcription.
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